EDAP TMS SA (EDAP)
3.75
+0.04
(+1.08%)
USD |
NASDAQ |
Mar 26, 15:06
EDAP TMS Cash from Investing (Quarterly) : -1.131M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| DBV Technologies SA | -0.2404M |
| Cellectis SA | 22.57M |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 0.00 |
| Evaxion AS | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.067M |
| Cash from Financing (Quarterly) | -1.677M |
| Free Cash Flow Per Share (Quarterly) | -0.1388 |
| Free Cash Flow to Equity (Quarterly) | -3.556M |
| Free Cash Flow to Firm (Quarterly) | -5.139M |
| Free Cash Flow Yield | -12.57% |